VEGF-A is widely accepted to be involved in the vascular complications related to diabetes; however, the alternative splice isoform VEGF-A165b has recently proven to be therapeutically beneficial in both type I and type II models of DN [7]. The gene discussed is VEGFA; the disease is diabetes mellitus.